“Maintenance of Response to Risankizumab in Patients With Psoriatic Arthritis: A 5-year Analysis of the KEEPsAKE 1 and 2 Trials” (2025) SKIN The Journal of Cutaneous Medicine, 9(6), p. s691. doi:10.25251/pwq1v445.